Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› L'Hospitalet de Llobregat
Clinical trial register · Spain

Clinical Trials in L'Hospitalet de Llobregat, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 113 Madrid 106 Seville 47 Valencia 38 L'Hospitalet de Llobregat 35
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca39 Merck Sharp & Dohme LLC35 Novartis Pharmaceuticals30 Hospital Universitari de Bellvitge27 Pfizer19 Clear sponsor filter
Site location
Barcelona113 Madrid106 Seville47 Valencia38 L'Hospitalet de Llobregat35
All 70 locations
Target enrolment
to

Trials with a site in L'Hospitalet de Llobregat

35 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 3
876
L'Hospitalet de Llobregat, Barakaldo, Barcelona, Málaga, Badajoz, Madrid, Seville, Valencia
2026-05-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
758
Seville, L'Hospitalet de Llobregat, Madrid, Barcelona, Las Palmas, Valencia
2026-04-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
L'Hospitalet de Llobregat, Santander, Girona, Madrid, Valencia, Barcelona, Córdoba
2025-11-26
Recruiting
Merck Sharp & Dohme LLC
Phase 2
250
L'Hospitalet de Llobregat, A Coruña, Madrid
2025-08-11
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Sacituzumab tirumotecan
Merck Sharp & Dohme LLC
Phase 3
2,400
L'Hospitalet de Llobregat, Bilbao, Salamanca, Jaén, Santiago de Compostela, Pozuelo de Alarcón, Valencia, Barcelona
2025-06-30
Recruiting
Merck Sharp & Dohme LLC
Phase 2
144
L'Hospitalet de Llobregat, Barcelona, Madrid, Seville
2025-05-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,123
L'Hospitalet de Llobregat, Girona, Barcelona, Córdoba, Madrid, Valencia
2025-05-22
Recruiting
Merck Sharp & Dohme LLC
Phase 2
96
L'Hospitalet de Llobregat, Madrid
2025-05-13
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
605
L'Hospitalet de Llobregat, Majadhonda, Madrid, Valencia, Barcelona, Málaga
2025-04-15
Recruiting
Merck Sharp & Dohme LLC
Phase 2
90
L'Hospitalet de Llobregat, Barcelona, Madrid
2025-03-30
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
270
L'Hospitalet de Llobregat, Barcelona, Madrid, Málaga
2025-03-25
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Seville, L'Hospitalet de Llobregat, Madrid, Valencia, Barcelona
2025-03-16
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
327
Eixample, L'Hospitalet de Llobregat, Madrid, Barcelona, Málaga
2025-02-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Seville, L'Hospitalet de Llobregat, Barakaldo, Las Palmas de Gran Canaria, Majadahonda, Gijón, Alicante, Barcelona
2025-01-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Barcelona, L'Hospitalet de Llobregat, Girona, Madrid, Valencia, Córdoba
2024-07-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Badalona, L'Hospitalet de Llobregat, Santander, Barcelona, Madrid, Marbella, Salamanca
2024-07-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Seville, L'Hospitalet de Llobregat, A Coruña, Madrid, Majadahonda, Valencia, Barcelona
2024-06-24
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
220
L'Hospitalet de Llobregat, Madrid, Barcelona
2024-05-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
780
L'Hospitalet de Llobregat, Santiago de Compostela, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Barcelona, Madrid
2024-04-03
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
L'Hospitalet de Llobregat, Girona, Madrid, Valencia, Barcelona, Córdoba
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
868
L'Hospitalet de Llobregat, Pozuelo de Alarcón, Majadahonda, Málaga, Barcelona, Seville
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Torrevieja, Córdoba, Málaga, Seville, Calella, Barcelona, Centelles, L'Hospitalet de Llobregat
2023-10-09
Active, closed
Merck Sharp & Dohme LLC
Phase 1
95
L'Hospitalet de Llobregat, Madrid, Barcelona, Seville
2023-07-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
280
L'Hospitalet de Llobregat, A Coruña, Madrid, Pamplona, Valencia, Barcelona, Seville
2022-02-03
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
110
L'Hospitalet de Llobregat, Barcelona
2021-08-19
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
L'Hospitalet de Llobregat, Salamanca, A Coruña, Alicante, Barcelona, Madrid
2021-04-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
L'Hospitalet de Llobregat, Oviedo, Barcelona, Madrid, Málaga, Seville
2020-12-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
520
L'Hospitalet de Llobregat, Valencia, Seville
2020-05-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
6,033
Badalona, Centelles, L'Hospitalet de Llobregat
2020-02-27
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
450
L'Hospitalet de Llobregat, Madrid
2019-12-19
Recruiting
Merck Sharp & Dohme LLC
Observational
1,065
L'Hospitalet de Llobregat, Barcelona, Madrid
2019-12-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,240
L'Hospitalet de Llobregat, A Coruña, Pozuelo de Alarcón, Madrid, Valencia, Barcelona, Jaén, Seville
2018-12-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
714
Badalona, L'Hospitalet de Llobregat, Santiago de Compostela, Barcelona, Madrid, Seville
2018-12-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Palma, Palma de Mallorca, L'Hospitalet de Llobregat, San Sebastian- Donostia, Santander, Badalona, Barcelona, Santiago de Compostela
2018-08-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Badalona, L'Hospitalet de Llobregat, Girona, Las Palmas de Gran Canaria, Barcelona, Madrid, Seville
2018-04-24
Rows per page Showing 1–35 of 35
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-spain/city/l-hospitalet-de-llobregat

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 35 of those studies with a site in L'Hospitalet de Llobregat that also match the filters currently applied.

How many clinical trials are recruiting in L'Hospitalet de Llobregat?

21 of the 35 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 14 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (L'Hospitalet de Llobregat), 35 studies
PhaseStudiesRecruitingShare
Phase 3221062.9%
Phase 1/26517.1%
Phase 25514.3%
Observational112.9%
Phase 1102.9%

Most active sponsors

Lead sponsors with the most studies (L'Hospitalet de Llobregat)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC3521
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.